Long term outcomes of Ranibizumab treatment in patients with diabetic macular edema in clinical practice

被引:0
|
作者
Regnard, Manar Addou [1 ]
Couturier, Aude [1 ]
Hage, Rabih [1 ]
Tadayoni, Ramin [1 ]
Massin, Pascale G. [1 ]
机构
[1] Lariboisiere Hosp, Ophthalmol, Paris, France
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1757
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice 1
    Plaza-Ramos, Pablo
    Borque, Enrique
    Garcia-Layana, Alfredo
    PLOS ONE, 2019, 14 (10):
  • [2] Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
    Van Aken, Elisabeth
    Favreau, Meredis
    Ramboer, Eva
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    Brie, Heidi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 4173 - 4185
  • [3] PRAGMATISM OF RANDOMIZED CLINICAL TRIALS ON RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA Impact on Clinical Outcomes
    Stewart, Stephen
    Yeong, Jian Lee
    Virgili, Gianni
    Azuara-Blanco, Augusto
    Lois, Noemi
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (05): : 919 - 927
  • [4] Evaluation of the efficacy of ranibizumab for the treatment of diabetic macular edema in daily practice
    Erginay, Ali
    Hage, Rabih
    El Sanharawi, Mohamed
    Dupas, Benedicte
    Jacob, Julie
    Massin, Pascale
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Ranibizumab for the treatment of diabetic macular edema in patients treated with Bevacizumab
    Velez, Gisela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [6] Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
    Heier, Jeffrey S.
    Bressler, Neil M.
    Avery, Robert L.
    Bakri, Sophie J.
    Boyer, David S.
    Brown, David M.
    Dugel, Pravin U.
    Freund, K. Bailey
    Glassman, Adam R.
    Kim, Judy E.
    Martin, Daniel F.
    Pollack, John S.
    Regillo, Carl D.
    Rosenfeld, Philip J.
    Schachat, Andrew P.
    Wells, John A., III
    JAMA OPHTHALMOLOGY, 2016, 134 (01) : 95 - 99
  • [7] Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting
    Hrarat, Linda
    Fajnkuchen, Franck
    Boubaya, Marouane
    Levy, Vincent
    Sarda, Valerie
    Grenet, Typhaine
    Nghiem-Buffet, Sylvia
    Chaine, Gilles
    Giocanti-Auregan, Audrey
    OPHTHALMOLOGICA, 2016, 236 (04) : 207 - 214
  • [8] Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
    Bandello, Francesco
    De Benedetto, Umberto
    Knutsson, Karl Anders
    Parodi, Maurizio Battaglia
    Cascavilla, Maria Lucia
    Iacono, Pierluigi
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 1303 - 1308
  • [9] Ranibizumab in diabetic macular edema
    Krispel, Claudia
    Rodrigues, Murilo
    Xin, Xiaoban
    Sodhi, Akrit
    WORLD JOURNAL OF DIABETES, 2013, 4 (06) : 310 - 318
  • [10] Ranibizumab for Diabetic Macular Edema
    Mayor, Rahul
    Agarwal, Manisha
    Singh, Shalini
    Venkatesh, Ramesh
    OPHTHALMOLOGY, 2013, 120 (01) : 221 - 221